[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_917 

# __Reduction in virus transmission__

## Description of Benefits pertaining to Beneficiaries

* [Private investors can benefit from the increased demand for and sales of antiviral coatings, leading to potential profit and market growth.](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_1006.md)
* [Improved safety and reduced risk for healthcare workers](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_1212.md)

## Stakeholders benefitting from this Benefit

* [healthcare workers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_68.md)
* [general public](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_29.md)
* [public places](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_367.md)
* [healthcare facilities](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_33.md)
* [schools](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_366.md)

## Articles mentionning this Benefit

* [Graphene-based nanomaterials as antimicrobial surface coatings: A parallel approach to restrain the expansion of COVID-19](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_187.md)
* [COVID-19 and its Modes of Transmission](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_225.md)

## Name of the Benefit

Reduces the risk of virus transmission and protects healthcare workers

